Literature DB >> 23215946

High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion.

Peng Chen1, Kai Li, Yan Liang, Liqing Li, Xiaolin Zhu.   

Abstract

Novel (nua) kinase family 1 (NUAK1) is a member of the human adenosine monophosphate (AMP)-activated protein kinase family that has been identified as a key tumor cell survival factor. In the present study, we investigated the role of NUAK1 in the migration and invasion of human nonsmall cell lung cancer (NSCLC) cells. Immunohistochemistry staining showed that the expression of NUAK1 correlated with the differentiation and stage of the carcinoma, as well as with lymph node metastasis. Inhibition of NUAK1 expression by small interference RNA severely impaired migration and invasion in A549 cells. In addition, we found that the knockdown of NUAK1 suppressed the expression of MMP-2 and MMP-9 and the activation of NF-kB, which can regulate the transcription of MMP-2 and MMP-9. Correspondingly, NUAK1 knockdown reduced lung metastasis in a xenograft mouse model of NSCLC. Taken together, our results suggest that NUAK1 plays an important role in NSCLC cell migration and invasion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23215946     DOI: 10.3109/01902148.2012.744115

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  15 in total

1.  Pharmacoproteomics Identifies Kinase Pathways that Drive the Epithelial-Mesenchymal Transition and Drug Resistance in Hepatocellular Carcinoma.

Authors:  Martin Golkowski; Ho-Tak Lau; Marina Chan; Heidi Kenerson; Venkata Narayana Vidadala; Anna Shoemaker; Dustin J Maly; Raymond S Yeung; Taranjit S Gujral; Shao-En Ong
Journal:  Cell Syst       Date:  2020-08-04       Impact factor: 10.304

2.  Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer.

Authors:  Xiao-tian Ye; Ai-jun Guo; Peng-fei Yin; Xian-dong Cao; Jia-cong Chang
Journal:  Med Oncol       Date:  2014-06-19       Impact factor: 3.064

3.  NUAK1 knockdown suppresses prostate cancer cell epithelial-mesenchymal transition, migration, and invasion through microRNA-30b-5p.

Authors:  Yongjun Guan; Hongbo Shi; Tianlin Xiao
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

4.  NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer.

Authors:  Neil T Phippen; Nicholas W Bateman; Guisong Wang; Kelly A Conrads; Wei Ao; Pang-Ning Teng; Tracy A Litzi; Julie Oliver; G Larry Maxwell; Chad A Hamilton; Kathleen M Darcy; Thomas P Conrads
Journal:  Front Oncol       Date:  2016-10-27       Impact factor: 6.244

5.  Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer.

Authors:  Yew Chung Tang; Szu-Chi Ho; Elisabeth Tan; Alvin Wei Tian Ng; John R McPherson; Germaine Yen Lin Goh; Bin Tean Teh; Frederic Bard; Steven G Rozen
Journal:  Breast Cancer Res       Date:  2018-03-22       Impact factor: 6.466

6.  microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.

Authors:  Mariko Obayashi; Maki Yoshida; Takaaki Tsunematsu; Ikuko Ogawa; Tomonori Sasahira; Hiroki Kuniyasu; Issei Imoto; Yoshimitsu Abiko; Dan Xu; Saori Fukunaga; Hidetoshi Tahara; Yasusei Kudo; Toshitaka Nagao; Takashi Takata
Journal:  Oncotarget       Date:  2016-02-16

7.  Calcium signalling links MYC to NUAK1.

Authors:  T Monteverde; J Tait-Mulder; A Hedley; J R Knight; O J Sansom; D J Murphy
Journal:  Oncogene       Date:  2017-11-06       Impact factor: 9.867

8.  Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response.

Authors:  Magali Champion; Kevin Brennan; Tom Croonenborghs; Andrew J Gentles; Nathalie Pochet; Olivier Gevaert
Journal:  EBioMedicine       Date:  2017-12-01       Impact factor: 8.143

9.  AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.

Authors:  Haokai Xu; Jiayan Mao; Xiaodan Yang; Fei Chen; Zhengwei Song; Jianguo Fei; Wei Chen; Zhengxiang Zhong; Xiaoguang Wang
Journal:  Mol Med Rep       Date:  2020-09-10       Impact factor: 2.952

10.  Dual targeting of NUAK1 and ULK1 using the multitargeted inhibitor MRT68921 exerts potent antitumor activities.

Authors:  Yiran Chen; Xiaoling Xie; Chunsheng Wang; Yuxing Hu; Honghao Zhang; Lenghe Zhang; Sanfang Tu; Yanjie He; Yuhua Li
Journal:  Cell Death Dis       Date:  2020-09-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.